United States · FDA National Drug Code directory
GABAPENTIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-7024_7a4c477a-2ba1-48c6-a959-b616343f8cdc
- Product NDC
- 68788-7024
- Form
- CAPSULE
- Composition / generic term
- GABAPENTIN
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200601
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (68788-7024-1) · 68788-7024-1
- 20 CAPSULE in 1 BOTTLE (68788-7024-2) · 68788-7024-2
- 30 CAPSULE in 1 BOTTLE (68788-7024-3) · 68788-7024-3
- 28 CAPSULE in 1 BOTTLE (68788-7024-4) · 68788-7024-4
- 60 CAPSULE in 1 BOTTLE (68788-7024-6) · 68788-7024-6
- 120 CAPSULE in 1 BOTTLE (68788-7024-8) · 68788-7024-8
- 90 CAPSULE in 1 BOTTLE (68788-7024-9) · 68788-7024-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →